Who Paid My Doc
Refobacin Bone Cement R
Device Cement
PDI 00880304990227
General payments
$17,673
Research payments
$58,750
Through program year 2025, $17,673 in general payments and $58,750 in research payments were reported against Refobacin Bone Cement R (Cement).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $31 | 1 |
| 2025 | Research | $27,500 | 2 |
| 2024 | General | $18 | 1 |
| 2024 | Research | $12,500 | 1 |
| 2023 | General | $22 | 1 |
| 2023 | Research | $18,750 | 1 |
| 2022 | General | $17,602 | 3 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
6 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.